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Moerman, D.E., 2012. Commentary: regression residual vs. bayesian analysis ofIn continuation of the discussion in an earlier issue (Leonti
t al., 2012; Moerman, 2012; Weckerle et al., 2011; Heinrich and
erpoorte, 2012) we have a related discussion in this issue about
ow ethnopharmacological data analysis could play a role in bio-
rospecting (Gertsch, 2012; Saslis-Lagoudakis et al., 2012). This
iscussion refers to the paper by Saslis-Lagoudakis et al. (2011).  In
act, this is a continuation of the discussion in a “setting standards”
aper on how to deal with ethnopharmacological data (Heinrich
t al., 2009).
Data analysis is one thing, collecting data another. In fact the pri-
ary data are the most important part of any research. When these
re available publicly, anyone may  try his or her preferred method
or extracting further information from these data. When the data
re recorded in a proper and reproducible way, datasets of differ-
nt experiments may  even be compared using various data analysis
ethods. In fact that is the dream of systems biology: without bias
aking observations, measurements, in a clearly deﬁned way and
reate public databases where these can be stored for future data
ining. The strength of such an approach is obvious in molecular
iology where gene and protein sequences can be stored in public
atabases for future use. Similarly one may  regard chemical struc-
ures as a method to store structural data of a compound in such
 way that it can be used for data mining. It is like eternalizing
nformation for future generations, like the Rosetta stone was for
eciphering Egyptian hieroglyphics.
In fact, for any study the crude primary data are the core of
he information, and these should be made available to the public.
eviewers in fact should ﬁrst of all scrutinize the experimental part
f any paper. The conclusions, in fact, are the authors’ interpretation
f the data, and can and should be a matter of continuous scientiﬁc
ebate. There are many examples of changes in our view of bio-
ogical and biochemical processes, but did that change the data of
arlier experiments? In the ﬁeld of natural products the biosynthe-
is of terpenes is a nice example. Hundreds of papers have reported
he incorporation of mevalonate in all kind of terpenoids, but since
he work of Rohmer et al. (1993) we know that there is another
athway that does not include mevalonate at all. Were all the pre-
ious papers wrong? No, only the conclusions. Can we blame the
eviewers of all the papers that reported mevalonate as an inter-
ediate for having done a poor job? No, they just accepted the
easoning of authors how to explain their results. This is just one
xample, but it shows the importance of making all primary data
vailable to the public.In a recent paper Alsheikh-Ali et al. (2011) showed that only 9%
f a set of 500 papers published in the 50 highest impact journals
ad the full primary data set of the experiments on-line available.
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Open access under CC BY-NC-ND license.Are we  doing better in JEP? At least we require that for each study
a herbarium voucher is deposited in an ofﬁcial herbarium, which
will enable future researcher to check the botanical identity and if
necessary even take probes for DNA or metabolomic proﬁling. For
the ethnopharmacological data collected in the ﬁeld we proposed
to construct a repository in which the primary data are stored
for future data mining (Verpoorte, 2008). This needs further
discussion, as all discussion about data analysis is meaningless if
we have no clear format for ethnopharmacological data. For the
journal we require that in one way or the other quantitative data
needs to be included to have some measure of the importance of
the information. With the data subsequently one may try to extract
further knowledge from the total dataset or by comparison of the
dataset with other datasets. This can be to prove a hypothesis or
to come to a new hypothesis. In such a systems biology approach
there would be no starting hypothesis and an unbiased data
collection would be the basis for an evaluation that may lead to
new hypotheses. But we  need to deﬁne what primary data need to
be recorded. Obviously the voucher specimen, the region and GPS
position of collection site of a plant, and how plants are processed
to become a medicine should be recorded, but the much more
difﬁcult part is how to measure the traditional knowledge about
diseases and how to diagnose, treat and cure these. Besides the
number of times plants are mentioned for certain applications,
it will be difﬁcult to qualify and quantify knowledge. I would
very much encourage further discussion about this in the ﬁeld of
ethnopharmacology.
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